More comprehensive discussion of CRC screening associated with higher screening

American Journal of Managed Care

Volumn 19, Issue 4, 2013, Pages 265-271

  Mosen, David M ^a   Feldstein, Adrianne C ^a,b   Perrin, Nancy A ^a   Rosales, A Gabriela ^a   Smith, David H ^a   Liles, Elizabeth G ^a,b   Schneider, Jennifer L ^a   Myers, Ronald E ^c   Elston Lafata, Jennifer ^d  

^a CENTER FOR HEALTH RESEARCH   (United States)

^b Northwest Permanente   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

^d VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER SCREENING; COLORECTAL CANCER; ELECTRONIC MEDICAL RECORD; HUMAN; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; PRIMARY MEDICAL CARE; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; HEALTH MAINTENANCE ORGANIZATIONS; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; OREGON; PHYSICIAN-PATIENT RELATIONS; PHYSICIANS, PRIMARY CARE; REFERRAL AND CONSULTATION; REMINDER SYSTEMS;

EID: 84877765868     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Jemal A, Tiwari RC, Murray T, et al. Cancer statistics, 2004. CA Cancer J Clin. 2004;54(1):8-29. (Pubitemid 38443417)
2. What are the key statistics for colorectal cancer? American Cancer Society website. www.cancer.org/.
3. Winawer SJ, Flehinger BJ, Schottenfeld D, Miller DG. Screening for colorectal cancer with fecal occult blood testing and sigmoidoscopy. J Natl Cancer Inst. 1993;85(16):1311-1318. (Pubitemid 23249723)
4. Mandel JS, Church TR, Bond JH, et al. The effect of fecal occultblood screening on the incidence of colorectal cancer. N Engl J Med. 2000;343(22):1603-1607. (Pubitemid 32162983)
5. Atkin WS, Cuzick J, Northover JM, Whynes DK. Prevention of colorectal cancer by once-only sigmoidoscopy. Lancet. 1993;341(8847): 736-740. (Pubitemid 23085190)
6. Whitlock EP, Lin JS, Liles E, Beil TL, Fu R. Screening for colorectal cancer: a targeted, updated systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2008;149(9):638-658.
7. Agrawal S, Bhupinderjit A, Bhutani MS, et al. Colorectal cancer in African Americans. Am J Gastroenterol. 2005;100(3):515-523. (Pubitemid 40487546)
8. Hoffman RM, Steel S, Yee EF, Massie L, Schrader RM, Murata GH. Colorectal cancer screening adherence is higher with fecal immunochemical tests than guaiac-based fecal occult blood tests: a randomized, controlled trial. Prev Med. 2010;50(5-6):297-299.
9. Federici A, Giorgi RP, Borgia P, Bartolozzi F, Farchi S, Gausticchi G. The immunochemical faecal occult blood test leads to higher compliance than the guaiac for colorectal cancer screening programmes: a cluster randomized controlled trial. J Med Screen. 2005;12(2):83-88. (Pubitemid 40835139)
10. Steinwachs D, Allen JD, Barlow WE, et al. National Institutes of Health state-of-the-science conference statement: enhancing use and quality of colorectal cancer screening. Ann Intern Med. 2010;152(10): 663-667.
11. Swan J, Breen N, Coates RJ, Rimer BK, Lee NC. Progress in cancer screening practices in the United States: results from the 2000 National Health Interview Survey. Cancer. 2003;97(6):1528-1540. (Pubitemid 36297783)
12. Seeff LC, Nadel MR, Klabunde CN, et al. Patterns and predictors of colorectal cancer test use in the adult U.S. population. Cancer. 2004;100(10):2093-2103. (Pubitemid 38580326)
13. Seeff LC, Shapiro JA, Nadel MR. Are we doing enough to screen for colorectal cancer? findings from the 1999 Behavioral Risk Factor Surveillance System. J Fam Pract. 2002;51(9):761-766. (Pubitemid 35006949)
14. Shapiro JA, Seeff LC, Nadel MR. Colorectal cancer-screening tests and associated health behaviors. Am J Prev Med. 2001;21(2):132-137. (Pubitemid 32660427)
15. Coughlin SS, Thompson TD. Colorectal cancer screening practices among men and women in rural and nonrural areas of the United States, 1999. J Rural Health. 2004;20(2):118-124. (Pubitemid 38380991)
16. Nadel MR, Blackman DK, Shapiro JA, Seeff LC. Are people being screened for colorectal cancer as recommended? results from the National Health Interview Survey. Prev Med 2002;35(3):199-206.
17. Bowie JV, Curbow BA, Garza MA, Dreyling EK, Benz Scott LA, McDonnell KA. A review of breast, cervical, and colorectal cancer screening interventions in older women. Cancer Control. 2005; 12(suppl 2):58-69.
18. Denberg TD, Melhado TV, Coombes JM, et al. Predictors of nonadherence to screening colonoscopy. J Gen Intern Med. 2005;20(11): 989-995. (Pubitemid 41726651)
19. Zapka JG, Puleo E, Vickers-Lahti M, Luckmann R. Healthcare system factors and colorectal cancer screening. Am J Prev Med. 2002;23(1):28-35. (Pubitemid 34687129)
20. Lafata JE, Divine G, Moon C, Williams LK. Patient-physician colorectal cancer screening discussions and screening use. Am J Prev Med. 2006;31(3):202-209. (Pubitemid 44176308)
21. Klabunde CN, Vernon SW, Nadel MR, Breen N, Seeff LC, Brown ML. Barriers to colorectal cancer screening: a comparison of reports from primary care physicians and average-risk adults. Med Care. 2005;43(9):939-944. (Pubitemid 41323144)
22. Brenes GA, Paskett ED. Predictors of stage of adoption for colorectal cancer screening. Prev Med. 2000;31(4):410-416.
23. O'Malley AS, Forrest CB, Feng S, Mandelblatt J. Disparities despite coverage: gaps in colorectal cancer screening among Medicare beneficiaries. Arch Intern Med. 2005; 165(18):2129-2135. (Pubitemid 41434589)
24. Freeborn DK. Promise and Performance in Managed Care: The Prepaid Group Practice Model. Baltimore, MD: John Hopkins University Press; 1994.
25. Mosen D, Feldstein A, Perrin N, et al. Automated telephone calls improved completion of fecal occult blood testing. Medical Care. 2010;48(7):604-610.
26. Braddock CH, III, Edwards KA, Hasenberg NM, Laidley TL, Levinson W. Informed decision making in outpatient practice: time to get back to basics. JAMA. 1999;282(24):2313-2320. (Pubitemid 30013062)
27. Braddock CH III, Fihn SD, Levinson W, Jonsen AR, Pearlman RA. How doctors and patients discuss routine clinical decisions: informed decision making in the outpatient setting. J Gen Intern Med. 1997;12(6):339-345. (Pubitemid 27255387)
28. Myers RE, Ross E, Jepson C, et al. Modeling adherence to colorectal cancer screening. Prev Med. 1994;23(2):142-151. (Pubitemid 24177854)
29. Myers RE, Sifri R, Hyslop T, et al. A randomized controlled trial of the impact of targeted and tailored interventions on colorectal cancer screening. Cancer. 2007;110(9):2083- 2091.
30. Myers RE, Hyslop T, Sifri R, et al. Tailored navigation in colorectal cancer screening. Med Care. 2008;46(9, suppl 1):S123-S131.
31. Schneeweiss S, Seeger JD, Maclure M, Wang PS, Avorn J, Glynn RJ. Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data. Am J Epidemiol. 2001;154(9): 854-864. (Pubitemid 33000813)
32. Schafer JF, Olsen MK. Multivariate imputation for multivariate missing-data problems: a data analyst's perspective. Multivariate Behavioral Research. 1998;33(4):545-571. (Pubitemid 128337068)
33. Lafata JE, Williams LK, Ben-Menachem T, Moon C, Divine G. Colorectal carcinoma screening procedure use among primary care patients. Cancer. 2005;104(7):1356-1361. (Pubitemid 41356150)
34. Ferrante JM, McCarthy EP, Gonzalez EC, et al. Primary care utilization and colorectal cancer outcomes among Medicare beneficiaries. Arch Intern Med. 2011;171(19):1747-1757.
35. Maxwell AE, Bastani R, Crespi CM, Danao LL, Cayetano RT. Behavioral mediators of colorectal cancer screening in a randomized controlled intervention trial. Prev Med. 2011;52(2):167-173.